Advanced practitioners (APs) in hematology and oncology work in various practice settings. Many of us are well trained to diagnose and manage common oncologic emergencies, such as acute renal failure, severe anemia, hypercalcemia of mali...
Many targeted therapies to treat genetic mutations in non–small cell lung cancer (NSCLC) have been developed. Amivantamab(Rybrevant), a bispecific antibody targeting the epidermal growth factor receptor (EGFR) and mesenchymal-epithelial ...
Aim: This study aimed to analyze articles that discussed the effect of music as adjunctive therapy to traditional treatments of pediatric cancer patients compared to a control of no music therapy. Background: Cancer is a leading cause of...
Melanoma is the fifth most common cancer in the United States, with over 7,000 deaths annually. Although most patients diagnosed with early-stage (stage I or II) disease have an excellent prognosis, two out of three patients who die from...
